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Abstract
Background: A number of studies have separately shown that the neuregulin1 (NRG1)/ErbB4 system and NMDA-
type glutamate receptors (NMDARs) are involved in several aspects of neuronal migration. In addition, intracellular
calcium fluctuations play central roles in neuronal motility. Stable expression of the tyrosine kinase receptor ErbB4
promotes migratory activity in the neural progenitor cell line ST14A upon NRG1 stimulation. In this work we
analyzed the potential interactions between the NRG1/ErbB4 system and NMDARs in the ST14A migratory process
as well as its calcium dependence.
Results: RT-PCR studies have shown that both native ST14A cells (non-expressing ErbB4), as well as ErbB4-
transfected cells express low levels of a restricted number of NMDAR subunits: NR1, NR2C, NR2D and NR3B. The
resulting NMDAR would form Ca2+ channels characterized by low Mg2+-sensitivity and low Ca2+-permeability,
generating small, long-lasting currents. Ca2+-imaging experiments showed slow [Ca2+]i increases in 45% of the cells
following 8 μM NMDA stimulation. Basal migration of ErbB4-transfected ST14A cells was unaffected by 18 hrs
NMDA incubation. However, over the same incubation time, NMDA was able to significantly enhance NRG1-
induced migration. Pre-incubation with the intracellular calcium chelator BAPTA-AM reduced both NRG1- and
NRG1/NMDA-stimulated migration, suggesting the involvement of Ca2+ in these processes. NRG1 stimulation of
ErbB4-transfected ST14A cells induced a sustained, long-lasting increase in [Ca2+]i, in 99% of the cells. These
intracellular Ca2+ signals could be ascribed to both release from intracellular stores and influx from the extracellular
medium trough a mechanism of store-operated calcium entry (SOCE). Short-time co-incubation of NMDA and
NRG1 did not substantially modify the NRG1-induced intracellular calcium signals.
Conclusions: In summary, NRG1 stimulation of the ErbB4 receptor exerts a sustained [Ca2+]i increase in ST14A
neural progenitors; NRG1-induced migration is Ca2+-dependent and can be positively modulated by activation of
the NMDA receptor.
Background
Neuroblast migration is a complex, integrated process
that involves a coordinated sequence of cellular events,
from surface receptor activation by external stimuli to
transduction of these stimuli by intracellular pathways
and subsequent dynamic cytoskeleton remodelling [1].
Many signalling molecules participate in the modulation
of neuronal migration, including molecules classified as
neurotransmitters and as growth/differentiation factors
[2,3].
The tyrosine kinase receptor ErbB4 binds members of
the Neuregulin (NRG) family of trophic and differentia-
tion factors. Receptor-ligand interaction induces the
homo- or heterodimerization with other members of the
ErbB receptor family, which in turn results in the
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activation of several intracellular signalling pathways and
the induction of cellular responses including migration
of neuronal precursor cells [4-6]. In vivo studies demon-
strate that the NRG1/ErbB4 system is involved in tan-
gential migration of olfactory bulb (OB) interneuron
precursors in the rostral migratory stream (RMS) [7]
and of cortical interneuron precursors migrating from
the ventral telencephalon [8].
The N-methyl-d-aspartate (NMDA)-type glutamate
receptor (NMDAR) is a calcium permeable channel
whose functions have been mainly characterized in exci-
tatory synapses of mature neurons. Recent studies
strongly suggest that glutamate may act as a paracrine
signal through NMDARs early expressed by neuronal
precursors and immature neurons [9]. NMDARs also
appear to be involved in several modes of migration in
vivo, such as radial migration of cerebellar granule cells
and tangential/radial migration in the developing cortex
[10-14].
In the last twenty years, several studies have pointed
to a key role of Ca2+ signalling in the control of neuro-
nal migration. Evidence came first from imaging studies
of granule cell migration in acute mouse cerebellar
slices, in which blockade or enhancement of Ca2+ influx
through N-type Voltage Dependent Calcium Channels
(VDCCs) or the NMDAR reduced or promoted the rate
of granule cell movement, respectively [10,15]. Similarly,
the involvement of calcium influx from the extracellular
medium has also been reported for the migration of
other cell types like GNRH-1 neurons, cortical projec-
tion neurons and interneurons [13,16-18].
In developing and mature neurons, NMDARs and the
NRG1/ErbB4 system have been found to interact in sev-
eral ways. In the cerebellar cortex, NRG1 release by
afferent fibres induces the expression of NR2C subunits
during synaptogenesis through the activation of ErbB4
receptors [19]; in the rat prefrontal cortex and in neuro-
nal primary cultures, NRG1 activation of ErbB4 modu-
lates NMDAR currents and regulates trafficking and
endocytosis of NMDAR subunits at excitatory synapses
[20]; NRG1 signalling through Fyn kinase modulates
NMDAR phosphorylation [21]; activity-driven glutama-
tergic synapse development is impaired by genetic defi-
cits in NRG1/ErbB4 signalling [22].
Up to now, no studies have analyzed the interaction
between these two systems in neuronal migration. The
present work is a first attempt to address this issue in a
simplified in vitro model of neural progenitors, the
ST14A cell line [23], in which NRG1/ErbB4 mediated
migration has been previously characterized [6,24]. As
expected from the expression data, we show that
NMDA induces small Ca2+ signals in ErbB4-transfected
ST14A cells. While NMDA does not modify basal
migration rates, it is able to increase NRG1-induced
migration. We provide evidence that both NRG1- and
NRG1+NMDA-induced migrations are calcium-depen-
dent processes. Indeed, NRG1 stimulation of ErbB4
receptors elicits long lasting increases in [Ca2+]i, with a
mechanism involving store-operated calcium entry
(SOCE). Short-time (minutes) co-incubation of NMDA
and NRG1 is not sufficient to significantly modify the
NRG1-induced calcium signals, suggesting a complex
mechanism of interaction requiring either a longer time
span or the generation of calcium signals confined to
subcellular domains not detectable with recordings of
changes in bulk cytosolic calcium concentration.
Results
NMDA does not modify basal migration of wild type
ST14A cells
NMDAR expression in wild type (wt) ST14A cells
Data from several groups have suggested that neural
stem cells and neural progenitors may express low levels
of the NMDA receptor [25,26]. We tested the expres-
sion of all known NMDAR subunits in wt ST14A cells
by RT-PCR. wt ST14A cells were grown at 33°C for 18
hrs in 2% FBS DMEM (same culture conditions as those
employed for subsequent migration assays) and were
harvested for RNA extraction. Figure 1A shows that
ST14A cells express the mRNAs of a restricted number
of NMDAR subunits: NR1, NR2C and NR2D. The use
of splicing-specific NR1 primer pairs allowed us to
determine that the most expressed isoform is NR1.4a.
This particular NR1 isoform lacks the N1 cassette
(coded by exon 5) and has a long intracellular tail lack-
ing the ER retention signal and containing a PDZ inter-
acting motif.
NMDA dose-response assay on viability of wt ST14A cells
Before testing the effects of NMDAR stimulation on wt
ST14A progenitor migration, we checked whether
NMDA could modify the total number of cells at the
concentrations employed in the subsequent migration
assays. NMDA at high concentrations can be cytotoxic,
depending on receptor density and subunit composition
[27]. NMDA could also increase cell proliferation and/
or survival, as demonstrated by several groups by in vivo
and in vitro experiments [28,29].
Wt ST14A cells were incubated with scalar concentra-
tions (1-10 μM) of NMDA for 18 hrs (the time length
used in all migration assays), then fixed and counted.
Results show that NMDA does not modify the total
number of cells (Figure 1B). This result suggests that, in
the concentration range 1-10 μM, NMDA has no excito-
toxic effects on wt ST14A cells. We consider very unli-
kely the occurrence of proliferative effects, due to the
low-serum culture conditions (2% instead of standard
10% serum) and the short incubation time (18 hrs) used
in these experiments. Compensatory effects of
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concurrent cell division and cell death are also very
unlikely; therefore, it can be safely assumed that the 1-
10 μM NMDA concentration range is suitable for
migration assays.
Transwell assays on NMDA-stimulated wt ST14A cells
ST14A cells have been generated from E14 striatum pri-
mordia. Therefore, we can assume that they mostly
derive from the lateral ganglionic eminence, a source of
a large number of migrating neuronal precursors. Wt
ST14A cell motility in un-stimulated conditions has
been previously described by other laboratories [30].
On this basis, we tested the hypothesis that NMDA
can modulate basal migration of wt ST14A cells, either
positively or negatively. Cells were treated for 18 hrs
with scalar concentrations of NMDA in a transwell
assay. Results clearly show that wt ST14A cells have a
low basal intrinsic motility that is not altered by the pre-
sence of NMDA (Figure 1C). On the other hand,
NMDA could have no effect per se in ST14A cell migra-
tion, and have instead an effect when added together
with other molecules, such as members of the neuregu-
lin family, and specifically NRG1, that has been shown
to promote ErbB4 mediated neuronal migration [6-8].
Wt ST14A cells do not express ErbB4; however, they
express other ErbB receptors, which could mediate a
NRG1-induced response in the presence of NMDA.
Figure 1 NMDA and NRG1 do not modify basal migration of wild-type ST14A neural progenitors. A: Agarose gel electrophoresis of RT-
PCR amplification products. Wt ST14A cells were cultured in 2% FBS DMEM for 18 hrs before total RNA isolation. Splicing-specific primer pairs
were employed to recognize N-terminal (1.a/1.b) and C-terminal (1.1/1.2; 1.3/1.4) splicing sites of the NR1 subunit. Wt ST14A express NR1.4a
(combination of 1.a N-term and 1.4 C-term splicing forms, see arrows), NR2C and NR2D subunits. No PCR product was observed in the absence
of reverse transcriptase (RT-) or cDNA (C-, water). “C-” reactions contained all primer pairs. C+ = various brain regions from adult rats. B: NMDA
dose-response assay on wt ST14A cells. Cells were incubated in increasing concentrations of NMDA (1, 2, 4, 10 μM) in 2% FBS DMEM for 18 hrs.
Data are expressed as mean + standard deviation (SD, n = 3). C: Effect of NMDA on wt ST14A cell migration measured by transwell assays
performed in 2% FBS DMEM for 18 hrs with different concentrations of NMDA. D: wt ST14A migration was measured by transwell assay with
addition of NMDA (8 μM) and NRG1 (5 nM) either alone or in combination. Representative images of migrated cells are shown above each bar/
treatment. Migration was calculated as percentage of total migrated cells (see Material and Methods). Biological triplicate experiments were
carried out in technical triplicate. Data are presented as means + SD. No statistically significant difference was found among different treatments.
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To test these hypotheses, we performed transwell
assays stimulating cells either with NRG1 alone or in
combination with 8 μM NMDA (Figure 1D). As
expected [6], NRG1 does not enhance migration of wt
ST14A, both when administered alone or in the pre-
sence of NMDA.
NMDA enhances NRG1-induced migration in ErbB4
transfected-ST14A cells
Our laboratory has previously shown that ST14A clones
stably transfected with different ErbB4 isoforms show a
variable degree of increased migratory activity when sti-
mulated by NRG1, depending on the specific ErbB4 iso-
form [6]. Since there are no data in the literature
comparing the interactions of different ErbB4 isoforms
with NMDARs, we used the two ErbB4 expressing
clones showing the highest increase in migration follow-
ing NRG1 stimulation. These clones express the JMa/
cyt2 ErbB4 isoform, containing a cleavage site for the
metalloprotease TACE in the juxtamembrane region,
and the JMb/cyt1 ErbB4 isoform, that has an intracellu-
lar binding site for PI3K. The latter, however, showed a
very high basal migratory activity in preliminary experi-
ments, making it more difficult to unmask the effect of
any molecule added to NRG1. Therefore, we chose a
JMa/cyt2 ErbB4 expressing clone (the clone A2.1, from
now on called “ErbB4-transfected cells”) characterized
by a lower level of basal migration.
As we did for wt ST14A cells, we tested the effect of
scalar concentrations of NMDA on the total number of
cells for 18 hrs. Again, we found that NMDA, in the
concentration range 1-10 μM, does not modify the total
number of cells (Figure 2B).
We subsequently performed transwell assays on
ErbB4-transfected cells stimulated with 8 μM NMDA,
or 5 nM NRG1, or the two drugs in combination, using
mock cells as a negative control (Figure 2C-D). Statisti-
cal analysis with two-way ANOVA revealed significant
main effects of drug treatment (F = 64.165, df = 3,16, P
= 3.88E-09) and of ErbB4 expression (F = 138.639, df =
1,16, P = 2.71E-09) and significant interaction between
the 2 factors (F = 50.474, df = 3,16, P = 2.22E-08). Post-
hoc comparison (Tukey’s test) showed that mock cells
do not show significant changes as compared to control
when stimulated with NRG1 alone, NMDA alone, or the
combination NRG1+NMDA; these results are in line
with those obtained with wt ST14A cells (Figure 1D). In
ErbB4-transfected cells, as expected, NRG1 induces a
highly significant increment in the number of migrated
cells (P = 2.24E-07), while NMDA alone does not signif-
icantly alter basal migration (P = 0.986). Intriguingly,
the combination of NMDA and NRG1 results in a sig-
nificantly higher migration rate as compared to that
observed with NRG1 alone (38% increase, P = 0.0056).
The addition of the NR2C/D subunit-specific antago-
nists PPDA (0.5 μM) and UBP141 (5 μM) was able to
decrease the combined effects of NRG1 and NMDA by
a similar extent (35-40% decrease of NRG1+NMDA sti-
mulated migration; see Additional files 1 and 2: Figure
S1 and S2). The channel blocker MK-801 (10 μM) and
the competitive antagonist D-AP5 (30 μM, acting at the
glutamate binding site on all NR2 subunits with affinity
ranking: NR2A≈2B > 2C≈2D) were also able to reduce
migration, albeit to a lesser extent (Additional file 1: Fig-
ure S1). Potential effects of all 4 NMDA antagonists on
cell number and viability were previously checked in a
dose-response assay over an 18 hrs period (data not
shown), to make sure that the agonist concentration
used in migration assays would not affect cell survival
and cell proliferation.
To better characterize the NMDAR subunits
expressed by ErbB4-transfected ST14A cells and com-
pare them to wt cells, we performed RT-PCR studies
with NMDAR subunit specific primers. Results indicate
that, as for wt ST14A cells, the ErbB4-transfected clone
expresses NR1.4a, NR2C and NR2D transcripts (Figure
2A). In addition, the NR3B subunit mRNA was found.
Generally, NMDARs are composed of at least one NR1
subunit and variable combinations of NR2/NR3 subu-
nits, generating NMDA receptors differing in their func-
tional characteristics and in cell-type and sub-cellular
localization [31]. The two NR2 subunits expressed by
ST14A cells (NR2C and NR2D) are prevalently extra-
synaptic and are characterized by low-conductance
openings and low sensitivity to Mg2+ block. NR3 subu-
nits act like a dominant negative, reducing the ampli-
tude of the response and its desensitization, and
decreasing the Ca2+ permeability of the NMDAR chan-
nel. We also quantified the expression of NMDAR subu-
nit mRNAs in mock and ErbB4-transfected ST14A cells
stimulated with NRG1, NMDA and the two molecules
together (data not shown); we found no evidence of reg-
ulation of NR1, NR2C, NR2D and NR3B subunit expres-
sion. Whether the NMDAR is regulated at a different
level (subunit translation, assembly, localization, phos-
phorylation) remains to be elucidated in future studies.
In summary, migration experiments performed with
NMDAR subunit-specific antagonists and expression
studies together suggest that NR1/NR2C/D-containing
NMDARs synergistically interact with the NRG1/ErbB4
system, ultimately producing a potentiation of ST14A
cell migration. A possible functional role of the NR3B
subunit remains to be ascertained.
Calcium is involved in NRG1-induced migration
BAPTA-AM dose-response assay on viability of ST14A cells
Neurotrophins, neurotransmitters and other extracellu-
lar signalling molecules have been shown to promote
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neuronal motility in a calcium-dependent way [12,32];
for this reason, we checked whether the migratory activ-
ity induced by NRG1, and its further enhancement
observed when NMDA is added to NRG1, are Ca2
+-dependent.
To evaluate the role of Ca2+ we treated cells with
BAPTA-AM, a Ca2+ chelator that can cross the mem-
brane and, once in the cytoplasm, is cleaved by endogen-
ous esterases thus buffering the increases in [Ca2+]i due
to extracellular influx or intracellular release from stores.
Just because of its pleiotropic effect, buffering intracellu-
lar Ca2+ can be dangerous and can affect processes like
cell adhesion to substrata or cell survival. To test the
effect of BAPTA-AM on cells, ErbB4-transfected cells
were incubated with scalar concentrations of BAPTA-
AM (5, 10, 15 μM) and the number of cells after 18 and
24 hrs was evaluated (data not shown). Since even during
the 24 hrs incubation the cell number was not affected
by the application of BAPTA-AM and no signs of cell
detachment were evident, we chose the higher concentra-
tion (15 μM) for the subsequent transwell assays.
Transwell assays on NMDA/NRG1-stimulated ErbB4-
transfected cells in the presence of BAPTA
Transwell assays were performed on ErbB4-transfected
cells previously incubated with 15 μM BAPTA-AM in
2% FBS-DMEM for 20 minutes (Figure 3A). Statistical
analysis with two-way ANOVA showed significant main
effects of drug treatment (F = 78.713, df = 3,16, P =
8.53E-10) and of intracellular Ca2+ chelation
(+/-BAPTA, F = 54.394, df = 1,16, P = 1,57E-06), with
significant interaction between the two factors (F =
8.939, df = 3,16, P = 0.0010). Posthoc comparison
Figure 2 NMDAR activation modulates NRG1-induced migration in ErbB4-transfected ST14A cells. A: ErbB4-transfected cells were cultured
in 2% FBS DMEM for 18 hrs before total RNA isolation. Agarose gel electrophoresis was used to separate RT-PCR amplification products obtained
with primer pairs specific for different NMDAR subunits (see Figure 1 for details). ErbB4-transfected cells express NR1.4a (arrows), NR2C, NR2D and
NR3B (arrow). Note that NR3B was absent in wt ST14A cells. No PCR product was observed in reactions that omitted either reverse transcriptase
(RT-) or starting material (C-, water). C- reaction contained all primer pairs. C+ = various brain regions from adult rats used as positive controls. B:
As for wt ST14A cells, NMDA (1-10 μM) did not change ErbB4-transfected cell number. Cells were incubated in increasing concentrations of
NMDA in 2% FBS DMEM for 18 hrs. Data are expressed as mean + SD (n = 3). C: Representative images of migrated cells showing that NMDA
enhances NRG1-induced migration in ErbB4-transfected cells. Cells were treated either with 8 μM NMDA, 5 nM NRG1 or both for 18 hrs. Scale
bar represents 200 μm. D: Histogram of the transwell experiment shown in C. Migration was calculated as percentage of total migrated cells as
described in Material and Methods. Biological triplicate experiments were carried out in technical triplicate. Data are presented as means + SD.
Statistical analysis was performed by applying two-way ANOVA, followed by Tukey’s posthoc test (see text for details), ** = p < 0.01.
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(Tukey’s test) showed that BAPTA-AM had no effect on
migration either in control conditions (P = 0.993) or in
the presence of NMDA (P = 0.560). Interestingly,
BAPTA-AM significantly decreased NRG1-induced
migration (40% reduction, P = 0.006) without abolishing
it completely (Figure 3B), implying that this migratory
mechanism is at least in part Ca2+-dependent. Further-
more, in the presence of BAPTA-AM, the NRG1 and
NRG1+NMDA conditions were not significantly differ-
ent (P = 0.450), meaning that BAPTA-AM is able to
prevent the cooperation between the pathways activated
by NMDA and NRG1 (Figure 3B).
The addition of the NR2C/D subunit-specific antago-
nists UBP141 (5 μM) did not further potentiate the
inhibitory effect of BAPTA (Additional file 1, Figure S2),
suggesting that this intracellular chelator is able to buf-
fer the Ca2+ entering the cell through the NMDAR.
Collectively, these data suggest that intracellular
BAPTA-AM, by buffering [Ca2+]i changes, interferes
with the NRG1-induced migration and antagonizes the
synergistic effect exerted by NMDA on NRG1.
Calcium signals induced by NRG1 and NMDA
Subsequently, we investigated if NRG1 stimulation in
ErbB4-transfected cells could elicit calcium signals. As
shown in Figure 4A, 5 nM NRG1 caused an elevation in
intracellular calcium. Responding cells were 99% (n =
454); mean peak amplitude was 0.68 ± 0.03 (Figure 4D).
In most cells, the signal was biphasic, a transient phase
being followed by a long lasting plateau. When the ago-
nist was washed out, [Ca2+]i remained at levels higher
than control for tens of minutes in most cells (Figure
4A); in some cells, it returned slowly to basal levels.
In order to distinguish the relative contributions of
extracellular Ca2+ influx and release from intracellular
stores, we performed the NRG1 stimulation in an extra-
cellular solution without Ca2+ and with 0.5 mM EGTA
added. Figure 4B shows that in the absence of extracel-
lular Ca2+ a lower and slowly decaying signal can be
observed, implying a contribution of Ca2+ released from
intracellular stores (responding cells 94%, n = 170; peak
amplitude 0.16 ± 0.01; see Figure 4D).
When Ca2+ was restored into the perfusion solution,
after NRG1 had been removed from the bath, a strong
increase in [Ca2+]i was observed in 78% of cells (Figure
4B, arrow). Mean ΔR was 0,34 ± 0,01. This effect can be
ascribed to store-operated calcium entry/SOCE [33], i.e.
to the influx of extracellular Ca2+ triggered by depletion
of intracellular stores.
This mechanism may account, either completely or
partially, for the long lasting plateau observed in 2 mM
extracellular Ca2+. To clarify this issue, we stimulated
the cells with 0.1 mM thapsigargin (TG) and, subse-
quently, during the plateau phase of the response, with
5 nM NRG1. TG induces irreversible depletion of ER
calcium stores and activates SOCE. With this protocol,
NRG1 did not elicit any additional increase in [Ca2+]i in
77 out of 78 cells responding to TG with a biphasic
response (transient followed by plateau), providing evi-
dence that the influx activated by NRG1 is almost totally
dependent on SOCE (Figure 4C).
When NRG1 was applied to mock transfected cells in
the presence of 2 mM extracellular Ca2+, no response
could be observed (n = 304; data not shown).
On the other hand, stimulation with 8 μM NMDA led
to a very slow increase in [Ca2+]i in 46% of cells tested
(n = 247, Figure 5A), reaching a value of 0.26 ± 0.01
(Figure 5D). More than 10 min were needed to reach
the plateau. This result is coherent with the low
Figure 3 Calcium is involved in NRG1-induced migration. A:
Representative images of migrated ErbB4-transfected cells in the
presence/absence of 15 μM BAPTA-AM, showing that both NRG1-
and (NRG1+NMDA)-induced migrations are reduced by buffering of
intracellular Ca2+. Cells were treated for 18 hrs with 8 μM NMDA, 5
nM NRG1 or both. B: Histogram of the same migration assay.
Migration was calculated as percentage of total migrated cells as
described in Material and Methods. Biological triplicate experiments
were carried out in technical triplicate. Data are presented as means
+ SD. Statistical analysis was performed by applying two-way
ANOVA, followed by Tukey’s posthoc test (see text for details) * = p
< 0.05; ** = p < 0.01; *** = p < 0.001.
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NMDAR expression level found in the ST14A cells, and
the peculiar time course of the response can be
explained by the reduced Mg2+ dependence of the
receptors present in these cells, that can allow for the
opening of some channels even at resting membrane
potentials; this activation may induce a slow depolariz-
ing response, that in turn may cause further channel
openings.
The specificity of the NMDA-induced [Ca2+]i elevation
was checked by employing the NR2C/D subunit-specific
antagonist UBP141. Due to the slow time course and
limited reversibility of the responses to NMDA, we did
not test UBP141 in acute protocols. Rather, we preincu-
bated the cells with the blocker (10 μM); following sti-
mulation with 8 μM NMDA, no response could be
detected (n = 57 cells, see Additional file 3: Figure S3).
To test the dependence of the observed increases in
[Ca2+]i from calcium influx from the extracellular med-
ium, cells were preincubated in a calcium-free extracel-
lular solution and subsequently challenged with 8 μM
NMDA: no response could be observed (n = 80 cells,
see Additional file 4: Figure S4).
We subsequently studied the effects of co-stimulation
with NRG1 and NMDA on Ca2+ signalling. When
NRG1 and NMDA were applied together, percentages
of responsive cells and peak values were not significantly
different from those obtained with NRG1 alone (99% of
218 cells; ΔR = 0.67 ± 0.03; Figure 5D). Plateau values,
too, were not significantly different between the two
conditions: NRG1, ΔR = 0.20 ± 0.007, n = 227; NRG1
+NMDA, ΔR = 0.18 ± 0.008, n = 218.
Notably, time to peaks were significantly shorter as com-
pared with those observed with separate stimulation with
either NRG1 or NMDA (Additional file 5: Figure S5); this
finding could imply that NMDA exerts some form of sen-
sitization on the pathway dependent on ErbB4.
When NMDA was removed from the extracellular
medium after the responses had already reached the pla-
teau phase, a limited decay in the plateau could be
observed (Figure 5B).
Figure 4 Acute stimulation with 5 nM NRG1 induces [Ca2+]i increases in ErbB4-transfected cells. ErbB4-transfected cells were loaded with
3 μM FURA-2-AM and perfused with a Tyrode Standard solution with or without calcium in the presence of 5 nM NRG1 in order to characterize
the [Ca2+]i changes induced by the factor. A: Mean ± SE from a representative experiment (n = 75), showing calcium induced by 5 nM NRG1 in
the presence of 2 mM extracellular [Ca2+]. B: Example of a response to 5 nM NRG1 in the absence of extracellular Ca2+ (0Ca). NRG1 induced a
slow increase due to release from intracellular stores; reintroduction of 2 mM [Ca2+] in the external bath induced a sustained increase of [Ca2+]i
(arrow). C: Lack of response to NRG1 in cells in which intracellular stores had been depleted by means of 0.1 mM thapsigargin (TG). Mean ± SE
from a representative experiment (n = 19). D: Histogram representing mean values of maximum amplitude (ΔR) responses to NRG1 in Tyrode
Standard solution and in the same solution without Ca2+ (n = 164 in Tyrode solution without Ca2+ ; 119 in Tyrode Standard). Data represent
means + SE from three independent experiments. *** p < 0.001 vs NRG1-Tyr.
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Finally, when NRG1 was applied during the slow
response to NMDA (Figure 5C), a biphasic increase in
[Ca2+]i was observed, with a peak amplitude not signifi-
cantly different (ΔR = 0,603 ± 0,028; n = 42) from the
responses to NRG1 alone.
Discussion
Neuronal migration is a tightly regulated process in
which the orchestrated activity of multiple molecules
combines to bring about the appropriate allocation of
post-mitotic nerve cells. Previous studies have shown
that the NRG1/ErbB4 system is involved in several types
of neuronal migration. On the other hand, intracellular
calcium fluctuations, in many cases regulated by influx
through Ca2+ permeable membrane channels, play cen-
tral roles in neuronal motility [32,34]; however, little is
known about the involvement of calcium signals in
NRG1-induced neuronal migration. In this work, we
analyzed the calcium dependence of the migratory-pro-
moting activity of the NRG1-ErbB4 system in immorta-
lized neural progenitors (ST14A cells), and the
interaction between this pathway and the one dependent
on the NMDA-type glutamate receptor, a calcium
permeable channel. Using ST14A cells exogenously
expressing ErbB4, we demonstrate that the two systems
synergistically act in stimulating progenitor cell migra-
tion in a Ca2+-dependent manner.
ST14A cells were chosen because they endogenously
express all members of the ErbB family (ErbB1, ErbB2,
and ErbB3) except ErbB4. We were able to compare
migratory activity in cells lacking and expressing ErbB4
by using wild type ST14A cells and clones permanently
transfected with specific ErbB4 isoforms [6]. Our RT-
PCR studies show that ErbB4-transfected cells, similarly
to wild type ST14A cells, express a restricted number of
NMDAR subunits: NR1.4a, NR2C, NR2D and NR3B.
Data from the literature indicate that the NR1 subunit is
essential for NMDAR trafficking and insertion into the
plasma membrane; different combinations of the NR2
and NR3 subunit families generate NMDA receptors dif-
fering in their functional characteristics, and cell-type
and sub-cellular localization [31]. The two NR2 subunits
expressed by ST14A cells (NR2C and NR2D) are preva-
lently extra-synaptic and are characterized by low-con-
ductance openings and low sensitivity to Mg2+ block
Figure 5 [Ca2+]i responses of ErbB4-transfected cells to NMDA
and NMDA+NRG1. We measured [Ca2+]i signals induced after an
acute stimulation with 8 μM NMDA and we compared them with
the ones obtained co-stimulating ErbB4-transfected cells with
NMDA and NRG1. A: Increases in [Ca2+]i induced by 8 μM NMDA in
the presence of 2 mM extracellular [Ca2+] differ from those elicited
when NRG1 is perfused: NMDA induced a very slow rise in [Ca2+]i
and the plateau was reached after several minutes. Mean ± SE from
a representative experiment (n = 69). B: The increase in [Ca2+]i
induced by co-stimulation with NRG1 and NMDA showed the same
amplitude and time course as NRG1-induced signals. Removal of
NMDA slightly affected the plateau phase. Mean ± SE from a
representative experiment (n = 82). C: When NRG1 was added
during the slow rising response to NMDA, a standard biphasic
increase in [Ca2+]i could be observed showing the same mean
amplitude as with NRG1 alone. Mean ± SE from a representative
experiment (n = 90). D: Histogram representing mean values of
maximum amplitude (ΔR) responses to NMDA, NRG1 and NMDA
+NRG1 in Tyrode Standard solution. (n = 197 with NRG; 118 with
NMDA and 216 with NMDA+NRG1). Data represent means + SE
from three independent experiments. *** p < 0.001 vs NRG1 and
NRG1+NMDA.
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[35-37]. On the other hand, NR3 subunits act like a
dominant negative, reducing the amplitude of the
response and its desensitization, and decreasing the Ca2
+ permeability of the NMDAR channel [38]. Since
usually NMDARs are composed of at least one NR1
subunit and variable combinations of NR2/NR3 subu-
nits, the resulting NMDARs would generate smaller,
long lasting currents, that are less Mg2+-sensitive and
Ca2+-permeable than those of NR2A-2B containing
NMDARs.
We did not find a statistically significant effect of
NMDA on basal migration of either wild type or ErbB4-
transfected ST14A cells; this finding could be ascribed
either to a low number of NMDA receptors on the
ST14A cell membrane, or to their reduced Ca2+ perme-
ability, yielding a Ca2+ influx not sufficient to elicit a
migratory response by itself.
ErbB4 expression is necessary for NRG1-induced
migration in ST14A progenitors. The mechanism has
been partly characterized in our laboratory in previous
studies [6]: ErbB4 dimerization and tyrosine kinase
trans-phosphorylation is followed by intracellular signal-
ling cascades involving PI3K activation. When NMDA
was added to NRG1 in migration assays, we found a sig-
nificant enhancement of migration compared to NRG1
alone (NRG1 alone: 5 fold, NRG1 + NMDA: 8 fold
increase in migration rate). This strengthening of
NRG1-stimulated migration is suggestive of a coopera-
tion between NMDA and ErbB4 receptors in inducing
and/or maintaining a migratory behaviour in ST14A
cells. The NMDA-mediated increase in NRG1-stimu-
lated migration could be prevented by the addition of a
NR2C/D subunit-specific antagonist (UBP141), strongly
suggesting that the NMDARs cooperating with ErbB4
during ST14A cells migration contain NR2C/D subunits.
The role of increases of the cytosolic calcium concen-
tration in controlling cell motility has been reported in
various cell types ranging from fibroblasts to immature
neurons [39,40]. Neuronal precursors and post-migra-
tory neurons in the fetal cerebrum and the early postna-
tal cerebellum exhibit spontaneous Ca2+ transients
[41,42], suggesting that the role of Ca2+ transients in
development may be constantly remodelled by internal
programs and extracellular cues. Ca2+ transients may
affect the recycling of cell-adhesion receptors and
induce the rearrangement of cytoskeletal components,
which are essential for cell movement. The spontaneous
Ca2+ transients in migrating granule cells are mediated
by NMDA receptors and by N-type Ca2+ VDCCs
[10,34]. Other agonists that can trigger an elevation in
[Ca2+]i involved in motility control are the neurotrans-
mitter GABA, that exerts an excitatory action in imma-
ture cells due to the high intracellular Cl- concentration,
the neuropeptide somatostatin that influences Ca2+
fluctuations in a stage-dependent manner, and neurotro-
phins, like Brain Derived Neurotrophic Factor
[13,43-45]. The ErbB4 receptor, like other members of
the ErbB family [46,47], upon ligand activation could eli-
cit calcium release from intracellular stores and calcium
influx. However, there are no data available for this
mechanism in neuronal cells, apart form a report [48]
indicating that NRG1 can modulate glutamate-induced
[Ca2+]i increase. Therefore, we checked if the synergism
of NMDAR and NRG1/ErbB4 systems in enhancing
ST14A migration could be due to a modulation of Ca2+
signalling.
In migration experiments carried out in the presence
of the intracellular Ca2+ chelator BAPTA-AM we found
a highly significant reduction both in NRG1 and in
NMDA+NRG1 stimulated migration, with the latter
reduced to the same level seen with NRG1 alone. This
result strongly supports the hypothesis that both NRG1
induced migration in ST14A cells and the synergistic
effect of NMDAR/ErbB4 activation involve intracellular
Ca2+ changes. For NRG1-induced migration, values in
the presence of BAPTA-AM were still significantly
higher than controls, indicating that NRG1/ErbB4-
induced migration could involve also Ca2+-independent
mechanisms.
In the attempt to understand the mechanisms under-
lying these calcium-dependent effects, we began to char-
acterize the Ca2+ signalling induced by NRG1 and
NMDA by means of calcium imaging experiments. Our
findings indicate that NRG1 stimulation of ErbB4-trans-
fected ST14A cells induces a long lasting increase in
[Ca2+]i, while no response could be recorded from mock
transfected cells. To clarify the relative contribution and
extent of calcium influx from the extracellular medium
and of release from internal stores, NRG1 stimulation
was repeated in a medium without Ca2+ and containing
the calcium chelator EGTA. Cells responded to NRG1
with an increase in free calcium, but the signal was sig-
nificantly smaller and showed a transient time course.
Intriguingly, after termination of NRG1 stimulation and
subsequent reinstatement of Ca2+ in the medium, the
level of [Ca2+]i was strongly increased. This finding can
be explained by the activation of a store-operated cal-
cium entry (SOCE) driven by channels activated in
response to depletion of the intracellular Ca2+ stores
(see e.g. 33). Accordingly, when the mechanism was
activated by emptying the intracellular stores by means
of thapsigargin, cells did not respond to a subsequent
stimulation with NRG1.
Stimulation with NMDA led to an increase in free
intracellular Ca2+ that was significantly smaller than the
one obtained with NRG1, could be observed in only
46% of cells tested and was completely abolished when
the cells were preincubated either in a calcium-free
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solution or in the presence of the NR2C/D subunit-spe-
cific NMDAR antagonist UBP141. Significantly, these
signals showed a very slow time course: more than 10
min were required to obtain a plateau value. This find-
ing can be explained by a very low level of activation of
NMDA channels at resting potentials, compatible with
the proposed reduced Mg2+ sensitivity of the subunits
expressed in our cells; a limited activation of these chan-
nels could induce some depolarization, thus slowly
recruiting additional channels. The slow time course of
activation of this mechanism, and the relatively low glo-
bal increase in calcium levels could not be sufficient to
promote cell motility.
When both agonists were applied simultaneously, or
when NRG1 was presented during the slow rising phase
of the NMDA response, peak amplitudes were not sig-
nificantly different from those obtained following stimu-
lation with NRG1 alone; however, when NMDA was
removed during the plateau phase of the response, that
can be ascribed to calcium influx, a slight reduction in
[Ca2+]i could be detected. Taken together, these obser-
vations can explain the different roles of the two ago-
nists in promoting migration of ST14A cells and their
calcium dependence: the slow and small increases in
[Ca2+]i elicited by NMDAR activation are not sufficient
to promote a significant amount of neuronal migration,
while the faster, stronger and sustained signals induced
by the NRG1/ErbB4 pathway are sufficient; however,
when NMDA is presented together with NRG1, the
small additional amount of calcium entering from the
extracellular medium can exert a synergistic effect, pos-
sibly by inducing calcium signals localized to cellular
subdomains (e.g. submembrane regions) that could con-
tribute to the enhancement of cell motility.
NRG1 is one among several candidate genes linked to
a relevant behavioural disease, schizophrenia. There are
many hypotheses on the pathogenesis of this disease:
some studies suggest that young-adult onset of schizo-
phrenia may originate from disarranged circuitry caused
by an altered migration of neuronal precursors during
pre- and post-natal brain development [49,50]. Accord-
ing to post-mortem studies, in the brain of schizophre-
nic patients there is an altered NRG1/ErbB4 signalling
and an hypo-functional glutamatergic system. Therefore,
the understanding of NMDAR-NRG1/ErbB4 interactions
during neural precursor migration may contribute to
reveal the molecular and cellular basis of schizophrenia
and of other neurodevelopmental disorders.
Conclusions
In summary, we present in this paper the first experi-
mental evidence that NRG1, by activating the ErbB4
receptor, can induce long lasting increases in intracel-
lular calcium in a line of striatal neural progenitors,
and that these signals are involved in the migratory
behaviour of these cells. The mechanism responsible
for these signals appears to be mainly dependent on
the activation of a store operated calcium influx.
Moreover, we suggest a role for NMDA receptors in
modulating NRG1/ErbB4-induced migration. This
interaction is calcium-dependent, even if the mechan-
ism responsible for this cooperative effect still needs to
be elucidated.
Methods
Reagents
All chemicals and reagents were purchased from Sigma
(St. Louis, MO), unless otherwise stated. The EGF-like
domain of mouse NRG1b1 (called NRG1 throughout
the article) was produced in our laboratory as a His-tag
fusion protein in Escherichia coli [51].
PPDA ((2R*,3S*)-1-(Phenanthrenyl-2-carbonyl)pipera-
zine-2,3-dicarboxylic acid cis), UBP141 ((2R*,3S*)-1-
(Phenanthrenyl-3-carbonyl)piperazine-2,3-dicarboxylic
acid)), (+)-MK801 ((5S,10R)-(+)-5-Methyl-10,11-dihy-
dro-5H-dibenzo[a, d]cyclohepten-5,10-imine maleate)
and D-AP5 (D-(-)-2-Amino-5-phosphonopentanoic acid)
were all purchased from Ascent Scientific (Bristol, UK).
BAPTA-AM (1,2-Bis(2-aminophenoxy)ethane-N, N, N’,
N’-tetraacetic acid tetrakis acetoxymethyl ester) was pur-
chased from Calbiochem. FURA-2-AM (Fura-2-acetoxy-
methyl ester) was from Molecular Probes Inc. All
reagents were resuspended and stored following the
manufacturer’s instructions.
Cell Culture
The ST14A cell line (kindly provided by prof. Elena Cat-
taneo), was derived from primary cells dissociated from
rat striatal primordia at embryonic day 14 and condi-
tionally immortalized by retroviral transduction of the
temperature-sensitive variant of the SV40 large T anti-
gen, as previously described [23]. Cells were cultured on
10 cm petri-dishes (BD Biosciences) in Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 100
units/ml penicillin, 0.1 mg/ml streptomycin, 1 mM
sodium pyruvate, 2 mM L-glutamine, and 10% or 2%
fetal bovine serum (FBS, GIBCO®, Carlsbad, CA, USA)
decomplemented at 56°C for 30 minutes. In this work
we used an ST14A clone stably expressing the JMa/cyt2
ErbB4 isoform (clone A2.1). ErbB4-stable transfectants
were previously obtained [6] subcloning the cDNA cor-
responding to this ErbB4 isoform into the pIRESpuro2
vector (Clontech) and stably transfecting wild type
ST14A cells as previously described. ErbB4-transfected
cells were grown in medium containing 5 μg/ml puro-
mycin. Cells were grown as monolayers at the permis-
sive temperature of 33°C in a 5% CO2, 95% air
atmosphere saturated with H2O. Cells were allowed to
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grow to near confluence, and adherent cells were har-
vested by the trypsin/EDTA method.
Dose-response assays
Preliminary drug dose-response assays were performed
to identify the correct drug concentration to be used in
migration experiments. NMDA dose-response treatment
was carried out by plating 105 cells in triplicate on 24-
well dishes, and treating cells for 18 hrs at 33°C with
scalar concentrations of NMDA (1, 2, 4, 10 μM) in 2%
FBS DMEM. For BAPTA-AM treatments, cells cultured
in 2% FBS were incubated 20 min with BAPTA-AM (5,
10, 15 μM), then the medium was changed and the cells
were incubated for 4 hrs at 33°C to avoid detachment
and to allow complete de-esterification of the interna-
lized BAPTA-AM; cells were then trypsinized and plated
on 6-well dishes at the density of 5 × 104 cells/well and
incubated at 33°C for 18 and 24 hrs. At the end of treat-
ments, cells were washed with PBS with calcium, fixed
in 2% glutaraldehyde for 20 min at RT, washed in water,
stained with 0.1% crystal violet, 20% methanol for 20
min at RT, washed in water and then analyzed.
Dose-response assay for NMDAR antagonists was car-
ried out plating 5 × 103 cells in 8 wells per condition on
96-multiwells. Cells were allowed to attach for 24 hrs in
10% FBS DMEM, then the medium was replaced with
2% FBS containing three concentration for each antago-
nist: PPDA (0.2-0.5-1 μM), UBP141 (2-5-10 μM), MK-
801 (5-10-20 μM), D-AP5 (10-50-100 μM). After 18 hrs,
cells were fixed in 2% glutaraldehyde for 20 min at
room temperature and then stained with 0.1% crystal
violet, 20% methanol solution for 20 min, washed in
water, and air-dried. Bound dye was solubilized by addi-
tion of 10% acetic acid (100 μl/well) and 5 min of shak-
ing at room temperature. The absorbance of dye
extracts was measured directly in plates using a Micro-
plate Reader (Bio-Rad) at a wavelength of 590 nm.
Transwell Assays
Transwell assays were carried out using cell culture
inserts (Cat. #353097, BD Biosciences) as described in
[6], with minor modifications. 7 × 104 cells resuspended
in 200 μl 2%FBS DMEM were seeded in the upper
chamber of the cell culture insert. The lower chambers
contained 0.8 ml 2%FBS DMEM as the control condi-
tion, or medium added with NRG1 and/or NMDA and/
or NMDA antagonists (5 nM NRG1, 8 μM NMDA, 5
μM UBP141, 0.5 μM PPDA, 10 μM MK-801, 30 μM D-
AP5). In migration experiments performed with the cal-
cium-chelator BAPTA-AM, cells were pretreated 20 min
in the culture plate with 15 μM BAPTA-AM in 2%FBS-
DMEM, then cultured 60 min in 2%FBS DMEM,
detached and counted for the transwell assay (control
cells were incubated 80 minutes in 2%FBS-DMEM). In
migration experiments performed with NMDA receptor
antagonists, (UBP141, PPDA, MK-801, D-AP5) cells
resuspended in 2%FBS-DMEM (3, 5 × 104 cells/ml)
were preincubated 20 minutes with antagonists, then
200 μl (7 × 104) cells were seeded in each upper cham-
ber. Cells were allowed to migrate 18 hrs at 33°C. At
the end of the incubation time, inserts were washed
twice in PBS, and the top side of the membrane was
wiped clean with cotton tipped applicators to eliminate
un-migrated cells. Migrated cells present on the lower
side of the filter were fixed in 2% glutaraldehyde for 20
minutes at room temperature and then stained with
0,1% crystal violet, 20% methanol solution for 20 min-
utes, washed in water, air-dried and then photographed
(four 8-bit images per well, 4× magnification) using an
inverted microscope Olympus IX50 equipped with a
Cool SNAP-Pro CCD camera. All conditions were per-
formed in triplicate. Four images were analyzed for each
transwell using the ImageJ software and the amount of
migrated cells was evaluated as the total area of migra-
tion (in pixel2) and then expressed as percentage of the
total number of migrated cells for every single experi-
ment, in order to normalize the variability between dif-
ferent experiments. Cells were discriminated by the
pores of the Transwell membrane by applying a thresh-
old of 300 pixel2. Statistical analysis was performed
using SPSS software on technical triplicates of three dif-
ferent experiments. The significance of effects of treat-
ment was assessed using the one or two-way ANOVA
followed by Tukey’s multiple comparisons with p < 0.05
considered significant.
RNA extraction and Reverse Transcription (RT)-PCR
Total RNA extraction was performed using TRIZOL®
Reagent (Invitrogen Life-Technologies) using a modified
protocol compared to the manufacturer’s instruction.
Briefly, following washing in PBS, 800 μl TRIZOL were
added to the dishes, cells were collected with a cell scra-
per and then transferred to a microcentrifuge tube on
ice. Samples were homogenized by several passages
through a 22G needle connected to a 1 ml syringe. Fol-
lowing the addition of chloroform and centrifugation,
the aqueous phase was transferred to a fresh tube and
RNA precipitated by isopropyl alcohol. The RNA pellet
was resuspended in 20 μl sterile water and treated with
DNAse (Promega) according to manufactory instruc-
tions. RNA was re-extracted in TRIZOL and quantified
by measuring absorbance at 260/280 nm; all samples
were diluted to the final concentration of 0.25 μg/μl.
Total RNA was reverse-transcribed into cDNA in a
reaction volume of 20 μl, containing 10 U M-MuLV
Reverse Transcriptase (Fermentas), 2.5 μM random hex-
amers (Fermentas), 50 mM Tris-HCl (pH 8.3 at 25°C),
75 mM KCl, 3 mM MgCl2, 10 mM DTT, 1 U/μl
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RiboLock™ RNase Inhibitor (Fermentas), 1 mM deoxy-
nucleotide triphosphates (dNTPs, Amersham-Bios-
ciences). RNA samples were denaturated 5 min at 80°C,
then incubated in the reaction mixture for 5 to 10 min
at 25°C followed by 60 min at 42°C and 5 min at 95°C.
cDNA products were diluted 1:3 in sterile water and
stored at -20°C.
PCR reactions were carried out for 30 (G3PDH) or 35
cycles (all other genes) in a total volume of 30 μl includ-
ing 3 μl cDNA, 0.5 μM of each primer pair, 1× standard
reaction buffer (10 mM Tris-HCl pH 8.3, 50 mM KCl,
1.1 mM MgCl2, 0.01% jelly), 200 μM dNTPs (Amer-
sham) and 0.025 U/μl of REDTaq DNA polymerase. Pri-
mer sequences, size of amplification products and
annealing temperatures are listed in Table 1. G3PDH
amplification was used to monitor the quality and quan-
tity of RNA that had been reverse-transcribed into
cDNA. Cycling parameters were set for each primer pair
in order to obtain specific products in the exponential
amplification phase of the PCR reaction. Negative con-
trols consisted in removal of reverse transcriptase (RT-)
from RT reaction and in replacement of cDNA with
sterile water (C-) in PCR reactions. Amplification pro-
ducts were separated by agarose gel electrophoresis and
DNA bands were visualized with ethidium bromide
staining and gel images were digitalized by Gel Doc
(Bio-Rad).
Calcium imaging
Loading of Ca2+ Indicator Dye
The [Ca2+]i in ST14A cells was monitored using the Ca
2
+ indicator dye FURA-2-AM. ST14A cells were plated
on poly-L-lysine coated glass coverslips contained in 60
mm dishes at a density of 5*103 cells/cm2 and left 3
days in 10% FBS, after which the medium was changed
to 2% FBS DMEM about one hour before the experi-
ment. Cells were loaded for 45 min at 37°C with 3 μM
FURA-2-AM in 2% FBS DMEM and subsequently
washed in Tyrode Standard Solution (Tyr-St: NaCl 154
mM, KCl 4 mM, CaCl2 2 mM, MgCl2 1 mM, HEPES 5
mM, glucose 5.5 mM, pH 7.34 with NaOH).
Calcium Measurements
After dye loading cells were transferred in a perfusion
chamber connected to a peristaltic pump and mounted
on an inverted microscope (Nikon TE-2000-S) equipped
with 20× magnification, a Xenon lamp illumination sys-
tem and a CCD camera. All experiments were performed
at room temperature. A gravity microperfusion system,
regulated by electrovalves, was employed to allow the
switch from the standard Tyrode solution to the same
medium containing drugs (5 nM NRG; 8 μM NMDA; 10
μM UBP141). Some experiments were performed in a
Tyrode solution without calcium (Tyr-0-Ca2+, 157 mM
NaCl, 4 mM KCl, 1mM MgCl2, 5 mM HEPES, 5.5 mM
glucose, 0.5 mM EGTA, pH 7.34 with NaOH) to evaluate
the contribution of calcium release from intracellular
stores. Calcium measurements were performed exciting
FURA-2-AM every 0.8 s alternatively at 340 nm and 380
nm, and emission was recorded at 510 nm. For each
experiment ROIs (Region of Interest) corresponding to
the cell bodies were chosen. The obtained fluorescence
values were plotted against time to generate graphics of
the intracellular Ca2+ trend in response to drug adminis-
tration. Images were visualized on a computer with the
dedicated acquisition software Metafluor (Universal Ima-
ging Corporation, PA). Data were analyzed with the
IGOR Pro software (6.03a version). Each experiment was
performed three times on different cell cultures, peak
values were calculated subtracting the baseline value for
each trace from the maximum value reached during drug
treatment. The statistical analysis was carried out using
SPSS software (descriptive statistics, ANOVA and non
parametric test) and data are represented as mean ± stan-
dard error or as percentages.
Additional material
Additional File 1: Figure S1 - Different NMDAR antagonists are able
to reduce the (NRG1+NMDA)-induced migration. ErbB4-transfected
ST14A cells were treated with 8 μM NMDA + 5 nM NRG1 for 18 hrs
(control condition) in the presence of various NMDA receptor
antagonists: PPDA (0.5 μM), UBP141 (5 μM), MK801 (10 μM) and D-AP5
(30 μM). Migration was calculated as percentage of total migrated cells
Table 1 PCR amplification primers
Gene Primer Sequence Size (bp) T(°
C)
G3PdH 5’-TGGCATTGTGGAAGGGCTCATGAC-3’ 188 60
5’-ATGCCAGTGAGCTTCCCGTTCAGC-3’
NR1 N-ter 5’-AGTCCAGCGTCTGGTTTGAGATGA-3’ 235(a)/298(b) 66
5’-CTCGCTTGCAGAAAGGATGATGAC-3’
NR2A 5’-TTCATCTGGGAGCACCTCTT-3’ 402 60
5’-GGCCACAAATGTTTGGAGTT-3’
NR2B 5’-GGCATTGCTATCCAAAAGGA-3’ 449 60
5’-GACAGGTTGGCCATGTTCTT-3’
NR2C 5’-GCACACCCACATGGTCAAGTTC-3’ 327 60
5’-CTGCTCATCACCTCATTCTTCT-3’
NR2D 5’-GCAATACCCACCTCTGAAGTTT-3’ 350 60
5’-CCAGCATCTCAATCTCATCGTC-3’
NR3A 5’-GGTTCCCTGCGGAAAGAGAAGC-3’ 310/370 60
5’-TACCATGAGCTGCTGGGGTCCC-3’
NR3B 5’-GGTTGGGGACAAAACCTTTGAGG-3’ 287 60
5’-CGGTGAGCAGCTTGCAGTCC-3’
NR1 C-ter 5’-ATGCCCCTGCCACCCTCACTTTTG-3’ 381(NR1.1)/270
(NR1.2)
70
5’-GCAGCTGGCCCTCCTCCCTCTCA-3’
NR1 C-ter 5’-TACAAGCGACACAAGGATGC-3’ 241(NR1.3)/132
(NR1.4)
60
5’-CGAGGGATCTGAGAGGTTGA-3’
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as described in Material and Methods. Data are presented as means +
SD (n = 3). Statistical analysis was performed by one-way ANOVA
followed by Tuckey’s test, *** = p < 0.001, ** = p < 0.01, * = p < 0.05.
Additional file 2: Figure S2 - The NR2C/D subunit-selective
antagonist UBP141 is able to inhibit the NMDA effect on NRG1-
induced migration. ErbB4-transfected cells were treated for 18 hrs with
different combinations of 8 μM NMDA, 5 nM NRG1, 5 μM UBP141 and
15 μM BAPTA-AM. Notice that UBP141 has no effect per se on ST14A cell
migration and that the presence of BAPTA completely masks the
inhibitory effect of UBP141 on (NRG1+NMDA)-induced migration.
Migration was calculated as percentage of total migrated cells as
described in Material and Methods. Biological triplicate experiments were
carried out in technical triplicate. Data are presented as means + SD.
Statistical analysis was performed by one-way ANOVA followed by
Tuckey’s post hoc test, significant differences vs control are indicated as *
= p < 0.05; ** = p < 0.01; *** = p < 0.001, while significant effects
between treatments are indicated as # p < 0.05; ## = p < 0.01; ### = p
< 0.001.
Additional file 3: Figure S3 - The NMDAR antagonist UBP141
suppresses NMDA-induced calcium signals. In the presence of 10 μM
UBP141, a NR2C/D subunit-specific NMDAR antagonist, stimulation with 8
μM NMDA failed to induce a response in 100% of 57 cells. A
representative trace is shown.
Additional file 4: Figure S4 - Responses to NMDA are abolished in
the absence of extracellular calcium. When cells were preincubated in
an extracellular solution containing 0 Ca2+ and 0.5 mM EGTA, no
response to 8 μM NMDA could be detected in 100% of 80 cells. The
mean ± SE is shown.
Additional file 5: Figure S5 - Times to peak of calcium increases
induced by the different agonists. Times to peak of the calcium
responses to NRG1 (n = 224), NMDA (n = 126) and to the combined
presence of the two agonists (n = 215). Values were respectively 290.5 ±
14.1; 592.4 ± 13.2 and 179.6 ± 3.8. ++ p < 0.01 vs. NRG1; ** p < 0.01 vs.
NMDA.
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